UniProt | Protein Name |
---|---|
Q9Y5P6 |
|
GO Term | Evidence Code | PMID |
---|---|---|
protein glycosylation | ||
GDP-mannose biosynthetic process |
GO Term | Evidence Code | PMID |
---|---|---|
mannose-1-phosphate guanylyltransferase (GTP) activity | ||
GTP binding | ||
protein binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:11723 | Duchenne muscular dystrophy | |
DOID:11724 | limb-girdle muscular dystrophy | |
DOID:11727 | facioscapulohumeral muscular dystrophy | |
DOID:11771 | spontaneous ocular nystagmus | |
DOID:11830 | myopia | |
DOID:11832 | visual epilepsy | |
DOID:11836 | clubfoot | |
DOID:11984 | hypertrophic cardiomyopathy | |
DOID:12215 | oligohydramnios | |
DOID:12270 | coloboma |
HPO ID | HPO Term |
---|---|
HP:0003327 | Axial muscle weakness |
HP:0003388 | Easy fatigability |
HP:0003391 | Gowers sign |
HP:0003394 | Muscle spasm |
HP:0003403 | EMG: decremental response of compound muscle action potential to repetitive nerve stimulation |
HP:0003457 | EMG abnormality |
HP:0003473 | Fatigable weakness |
HP:0003546 | Exercise intolerance |
HP:0003549 | Abnormality of connective tissue |
HP:0003551 | Difficulty climbing stairs |
Disease ID | Disease Name |
---|---|
ORPHA:363623 |
|
ORPHA:370968 |
|
ORPHA:370959 |
|
OMIM:615351 |
|
OMIM:615350 |
|
ORPHA:353327 |
|
ORPHA:588 |
|
OMIM:615352 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
105573696 | CERAT32380 | ||
705454 | MACMU29533 | ||
105480447 | MACNE07039 | ||
101018643 | PAPAN24657 | ||
105540343 | MANLE07261 | ||
101142350 | GORGO29480 | ||
100986111 | PANPA27885 | ||
460378 | PANTR31162 | ||
100436355 | PONAB25882 | ||
100856660 | CANLF07498 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024